A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults

Summary

The purpose of this study is to demonstrate the efficacy of the RSV F vaccine at a dose of 135µg via intramuscular (IM) injection in the prevention of moderate-severe RSV-associated lower respiratory tract disease (RSV-LRTD) in older adults ≥ 60 years of age.

Timeline

Start

2015-11

Primary completion

2016-12

Completion

2016-12

Drugs

Indications